(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium

DB02648ExperimentalSmall molecule

Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. [PubChem].

Formula / weight: C₇H₁₆NO₃ · 162.2068 g/mol (avg)

Resolves to

Compound

CAS461-06-3ChEMBLCHEMBL1229656ChEBI39547PubChem10918KEGGC00487

Structure

InChIKeyPHIQHXFUZVPYII-ZCFIWIBFSA-OSMILESC[N+](C)(C)C[C@H](O)CC(O)=O

Targets

P43155CRATQ9UKG9CROT

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account